FAM21C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.431980E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.495400E-01
Normal-vs-Stage2
1.279860E-02
Normal-vs-Stage3
7.564300E-02
Normal-vs-Stage4
4.753800E-01
Stage1-vs-Stage2
6.853000E-01
Stage1-vs-Stage3
4.254100E-02
Stage1-vs-Stage4
1.147770E-01
Stage2-vs-Stage3
1.180190E-01
Stage2-vs-Stage4
1.388580E-01
Stage3-vs-Stage4
2.147600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.783780E-02
Normal-vs-AfricanAmerican
1.634850E-01
Normal-vs-Asian
4.246100E-02
Caucasian-vs-AfricanAmerican
7.755800E-01
Caucasian-vs-Asian
7.037400E-01
AfricanAmerican-vs-Asian
5.709600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.037900E-02
Normal-vs-Female
1.540400E-02
Male-vs-Female
6.077400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.269600E-01
Normal-vs-Age(41-60Yrs)
3.726800E-01
Normal-vs-Age(61-80Yrs)
1.556430E-02
Normal-vs-Age(81-100Yrs)
3.096200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.025000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.196400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.065800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.283600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.749400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.624200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.401650E-02
Normal-vs-Daily Drinker
5.001600E-02
Normal-vs-Weekly Drinker
9.955600E-02
Normal-vs-Occasional Drinker
1.621150E-01
Normal-vs-Social Drinker
1.507760E-01
Non Drinker-vs-Daily Drinker
3.527800E-01
Non Drinker-vs-Weekly Drinker
1.338570E-01
Non Drinker-vs-Occasional Drinker
2.352000E-01
Non Drinker-vs-Social Drinker
1.818790E-01
Daily Drinker-vs-Weekly Drinker
5.277000E-01
Daily Drinker-vs-Occasional Drinker
7.011600E-01
Daily Drinker-vs-Social Drinker
6.036000E-01
Weekly Drinker-vs-Occasional Drinker
8.708600E-01
Weekly Drinker-vs-Social Drinker
9.556200E-01
Occasional Drinker-vs-Social Drinker
9.176000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.194400E-01
Normal-vs-Grade 2
6.432200E-01
Normal-vs-Grade 3
2.170800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.614000E-01
Grade 1-vs-Grade 3
8.442000E-01
Grade 1-vs-Grade 4
3.194400E-01
Grade 2-vs-Grade 3
9.063000E-01
Grade 2-vs-Grade 4
6.432200E-01
Grade 3-vs-Grade 4
2.170800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.486100E-02
Normal-vs-NonDiabetic
2.901400E-01
Diabetic-vs-NonDiabetic
3.806200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.445380E-01
Normal-vs-NoPancreatitis
1.114320E-02
Pancreatitis-vs-NoPancreatitis
1.588210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.056400E-01
Normal-vs-N1
1.749700E-02
N0-vs-N1
9.661800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.479800E-01
Normal-vs-TP53-NonMutant
7.331700E-02
TP53-Mutant-vs-TP53-NonMutant
2.397800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
